$69.43-0.90 (-1.28%)
Ralliant Corporation engages in the design, development, manufacture, sale, and service of precision instruments and engineered products in the United States, China, and internationally.
Ralliant Corporation in the Technology sector is trading at $69.43 with a market capitalization of $7.7B. Wall Street consensus targets $71.18 (11 analysts), implying a +2.5% move over the next 12 months. The stock is currently near its 52-week high of $75.41, remaining 34.7% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $534.60Mβ | $554.50Mβ | $529.10Mβ | $503.30Mβ | $481.80M |
| Gross Profit | $272.30Mβ | $279.90Mβ | $268.60Mβ | $248.30Mβ | $243.40M |
| Operating Income | $68.10Mβ | $73.90Mβ | $52.00Mβ | $58.90Mβ | $73.80M |
| Net Income | $44.20Mβ | -$1.37Bβ | $39.90Mβ | $47.60Mβ | $63.90M |
Ralliant Corporation engages in the design, development, manufacture, sale, and service of precision instruments and engineered products in the United States, China, and internationally. It operates through two segments, Test and Measurement; and Sen...
Here is how AirJoule Technologies Corporation (AIRJ) and Ralliant (RAL) have performed compared to their sector so far this year.
MIND faces delayed customer spending and a weaker backlog, but its high-margin aftermarket business, debt-free balance sheet and strong liquidity support long-term growth potential.
PSN vs. RAL: Which Stock Is the Better Value Option?
WCN has outpaced its industry in the past month, but the bigger reason why investors may want to hold on to the stock lies deeper in its growth story.
Here is how Healthcare Services (HCSG) and Ralliant (RAL) have performed compared to their sector so far this year.